MSFT vs NKTR · P/E 39, rev $331.84B vs rev $21.0M
Microsoft Corporation (MSFT) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Microsoft Corporation (MSFT) is a software - infrastructure company listed on US. It is led by Satya Nadella.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported MSFT revenue for 2026-06-30 was $331.84B. Net income was $133.75B. Revenue was up 17.8% from 2025-06-30 to 2026-06-30. MSFT currently screens at market cap $3.71T and trailing P/E 38.6.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
MSFT currently screens at market cap $3.71T and trailing P/E 38.6. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the MSFT and NKTR stock pages for the full models.
Not investment advice.